Rapamycin for longevity is currently one of the most researched topics in anti-aging science. It showed potential to improve healthspan by mimicking the biological effects of fasting. [Read more…]
Shockwave Therapy and Injury Recovery: Where the Evidence Stands
Sponsored Content
A treatment described as “regenerative” can sound more established than it is. The term appears in discussions of stem cells, biologic products, rehabilitation, and devices that act on tissue from outside the body. These approaches differ considerably, so the useful question is what a particular treatment does and what outcomes have been studied. [Read more…]
The Future of Drug Safety: How AI-Driven Literature Screening is Replacing Manual Labor
Modern healthcare technology is shifting rapidly, making it essential for pharmacovigilance (PV) teams to automate PV workflows using intelligent digital solutions. As the volume of global medical publications grows, traditional manual literature screening methods are increasingly difficult to sustain. This digital transformation is changing how pharmaceutical companies, contract research organizations (CROs), marketing authorization holders (MAHs), and pharmacovigilance specialists monitor adverse events, manage safety signals, and protect patient health across various medical disciplines, including specialized fields like orthopedics. [Read more…]
MUSE Cells Now Available at Longevity Medical Institute®
As part of its Regenerative Neurology Program, Longevity Medical Institute® is making MUSE cell therapy available to select patients, using cells produced in-house at the Institute’s biotechnology laboratory.
SAN JOSÉ DEL CABO, BAJA CALIFORNIA SUR, MEXICO, September 18, 2026 – Longevity Medical Institute® today announced the addition of MUSE cells to the advanced cell types produced in its in-house biotechnology laboratory.
“By isolating, enriching, and characterizing the MUSE cell population within the MSC cultures already produced in our in-house biotechnology laboratory, we have greater control over quality evaluation, release, and delivery for patient care,” said Dr. Kirk Sanford, founder and CEO of Longevity Medical Institute.
Longevity Medical Institute’s exclusive biotechnology partner, ITC, developed the MUSE stem cell product. MUSE stands for multilineage-differentiating stress-enduring. The recognized starting phenotype includes SSEA-3 and CD105 double positivity, supported by OCT3/4, SOX2, and NANOG. S1PR2 is associated with their proposed injury-directed migration. [Read more…]
Data-Driven Healthcare Starts With Better Patient Insights
Modern medicine generates massive amounts of digital information every single day. Hospitals routinely track everything from heart rates and lab results to medication schedules with extreme precision. These measurements build a comprehensive record of clinical care inside the facility. [Read more…]